Smyrlis A, Kogias D, Chalkidou A, Panagoutsos S, Kantartzi K, Papadopoulos V
Hippokratia. 2024; 28(1):22-28.
PMID: 39399404
PMC: 11466106.
Kim Y, Mills D
Food Sci Biotechnol. 2024; 33(9):2065-2080.
PMID: 39130661
PMC: 11315840.
DOI: 10.1007/s10068-024-01620-1.
Kayakiran G, Koyuncu S, Kocyigit I, Ozbakir O
Int Urol Nephrol. 2024; 56(10):3343-3350.
PMID: 38780893
DOI: 10.1007/s11255-024-04044-2.
Shi H, Shen Y, Li L
Front Med (Lausanne). 2023; 10:1221602.
PMID: 37720504
PMC: 10501398.
DOI: 10.3389/fmed.2023.1221602.
Sumida K, Pierre J, Yuzefpolskaya M, Colombo P, Demmer R, Kovesdy C
Semin Nephrol. 2023; 43(2):151408.
PMID: 37619529
PMC: 10783887.
DOI: 10.1016/j.semnephrol.2023.151408.
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.
Di Paola R, De A, Izhar R, Abate M, Zappavigna S, Capasso A
Genes (Basel). 2023; 14(6).
PMID: 37372437
PMC: 10298729.
DOI: 10.3390/genes14061257.
Bacterial metabolites and cardiovascular risk in children with chronic kidney disease.
Schlender J, Behrens F, McParland V, Muller D, Wilck N, Bartolomaeus H
Mol Cell Pediatr. 2021; 8(1):17.
PMID: 34677718
PMC: 8536815.
DOI: 10.1186/s40348-021-00126-8.
The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J, Franczyk B, Lawinski J, Olszewski R, Cialkowska-Rysz A, Gluba-Brzozka A
Toxins (Basel). 2021; 13(4).
PMID: 33807343
PMC: 8067083.
DOI: 10.3390/toxins13040252.
The clinical impact of gut microbiota in chronic kidney disease.
Kim S, Song I
Korean J Intern Med. 2020; 35(6):1305-1316.
PMID: 32872729
PMC: 7652652.
DOI: 10.3904/kjim.2020.411.
Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients.
He H, Xie Y
Biomed Res Int. 2020; 2020:6739762.
PMID: 32685517
PMC: 7321504.
DOI: 10.1155/2020/6739762.
Metabolic profiling of a chronic kidney disease cohort reveals metabolic phenotype more likely to benefit from a probiotic.
Saggi S, Mercier K, Gooding J, Friedman E, Vyas U, Ranganathan N
Int J Probiotics Prebiotics. 2019; 12(1):43-54.
PMID: 30774576
PMC: 6377160.
Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study.
Wang W, Hao G, Pan Y, Ma S, Yang T, Shi P
BMC Nephrol. 2019; 20(1):57.
PMID: 30764800
PMC: 6376694.
DOI: 10.1186/s12882-019-1238-9.
The role of chronic kidney disease-associated dysbiosis in cardiovascular disease.
Bryniarski M, Hamarneh F, Yacoub R
Exp Biol Med (Maywood). 2019; 244(6):514-525.
PMID: 30682892
PMC: 6547008.
DOI: 10.1177/1535370219826526.
Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.
Yacoub R, Nadkarni G, McSkimming D, Chaves L, Abyad S, Bryniarski M
Exp Biol Med (Maywood). 2018; 244(6):505-513.
PMID: 30539656
PMC: 6547006.
DOI: 10.1177/1535370218818175.
Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis.
Pisano A, DArrigo G, Coppolino G, Bolignano D
Nutrients. 2018; 10(9).
PMID: 30181461
PMC: 6165363.
DOI: 10.3390/nu10091224.
Altered gut microbiota and microbial biomarkers associated with chronic kidney disease.
Lun H, Yang W, Zhao S, Jiang M, Xu M, Liu F
Microbiologyopen. 2018; 8(4):e00678.
PMID: 30088332
PMC: 6460263.
DOI: 10.1002/mbo3.678.
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD).
Simeoni M, Citraro M, Cerantonio A, Deodato F, Provenzano M, Cianfrone P
Eur J Nutr. 2018; 58(5):2145-2156.
PMID: 30076458
PMC: 6647244.
DOI: 10.1007/s00394-018-1785-z.
In vitro effect of uremic serum on barrier function and inflammation in human colonocytes.
de Andrade L, Dalboni M, Carvalho J, Grabulosa C, Pereira N, Aoike D
J Bras Nefrol. 2018; 40(3):217-224.
PMID: 29944162
PMC: 6533953.
DOI: 10.1590/2175-8239-jbn-3949.
Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.
Hoibian E, Florens N, Koppe L, Vidal H, Soulage C
Toxins (Basel). 2018; 10(5).
PMID: 29772737
PMC: 5983260.
DOI: 10.3390/toxins10050204.
Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis.
Chaves L, McSkimming D, Bryniarski M, Honan A, Abyad S, Thomas S
Am J Physiol Renal Physiol. 2018; 315(3):F487-F502.
PMID: 29693447
PMC: 6172581.
DOI: 10.1152/ajprenal.00092.2018.